These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8417070)

  • 1. Use of nonionic or low osmolar contrast agents in cardiovascular procedures. American College of Cardiology Cardiovascular Imaging Committee.
    Ritchie JL; Nissen SE; Douglas JS; Dreifus LS; Gibbons RJ; Higgins CB; Schelbert HR; Seward JB; Zaret BL
    J Am Coll Cardiol; 1993 Jan; 21(1):269-73. PubMed ID: 8417070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonionic contrast use in cardiac angiography.
    Hill JA
    Invest Radiol; 1993 Nov; 28 Suppl 5():S48-53; discussion S54. PubMed ID: 8282503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
    Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
    N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a contrast agent in the cardiac catheterization laboratory.
    Brinker JA
    Am J Cardiol; 1990 Oct; 66(14):26F-33F. PubMed ID: 2239697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast agents for cardiac catheterization: conceptions and misconceptions.
    Brogan WC; Hillis LD; Lange RA
    Am Heart J; 1991 Oct; 122(4 Pt 1):1129-35. PubMed ID: 1927863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ionic and low-osmolar contrast media during cardiac catheterization.
    Davidson CJ; Bashore TM
    Trends Cardiovasc Med; 1991 Mar; 1(2):86-91. PubMed ID: 21239336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance.
    Levine GN; Gomes AS; Arai AE; Bluemke DA; Flamm SD; Kanal E; Manning WJ; Martin ET; Smith JM; Wilke N; Shellock FS; ; ;
    Circulation; 2007 Dec; 116(24):2878-91. PubMed ID: 18025533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast nephropathy, cardiology and the newer radiocontrast agents.
    Taliercio CP; Burnett JC
    Int J Cardiol; 1988 May; 19(2):145-51. PubMed ID: 3286534
    [No Abstract]   [Full Text] [Related]  

  • 11. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
    Patel MR; Bailey SR; Bonow RO; Chambers CE; Chan PS; Dehmer GJ; Kirtane AJ; Wann LS; Ward RP
    J Am Coll Cardiol; 2012 May; 59(22):1995-2027. PubMed ID: 22578925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons.
    Patel MR; Bailey SR; Bonow RO; Chambers CE; Chan PS; Dehmer GJ; Kirtane AJ; Wann LS; Ward RP; Douglas PS; Patel MR; Bailey SR; Altus P; Barnard DD; Blankenship JC; Casey DE; Dean LS; Fazel R; Gilchrist IC; Kavinsky CJ; Lakoski SG; Le DE; Lesser JR; Levine GN; Mehran R; Russo AM; Sorrentino MJ; Williams MR; Wong JB; Wolk MJ; Bailey SR; Douglas PS; Hendel RC; Kramer CM; Min JK; Patel MR; Shaw L; Stainback RF; Allen JM
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):E50-81. PubMed ID: 22678595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.
    Davidson CJ; Hlatky M; Morris KG; Pieper K; Skelton TN; Schwab SJ; Bashore TM
    Ann Intern Med; 1989 Jan; 110(2):119-24. PubMed ID: 2909204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient choice and nonionic contrast media.
    Hopper KD; Matthews YL
    Invest Radiol; 1993 Apr; 28(4):303-7. PubMed ID: 8478170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The choice of contrast agents in the cardiac catheterization laboratory.
    Morton BC
    Can J Cardiol; 1989; 5(8):379-81. PubMed ID: 2605547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic vs. nonionic contrast media.
    Lloyd K
    Radiol Technol; 1994; 66(1):57-9. PubMed ID: 7997528
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of thrombogenicity among nonionic radiocontrast agents.
    Georgakis A; Ener RA; Jin J; Kunapuli S; Fiss D; Leech SH; Wolf NM; Van Decker WA
    J Invasive Cardiol; 2008 Jul; 20(7):349-53. PubMed ID: 18599893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrenal Complications of Contrast Media.
    Krause D; Marycz D; Ziada KM
    Interv Cardiol Clin; 2020 Jul; 9(3):311-319. PubMed ID: 32471672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of heparinized low osmolality ionic and nonionic contrast media in 500 patients undergoing cardiac angiography.
    Feldman RL
    Clin Cardiol; 1990 Nov; 13(11):794-6. PubMed ID: 2272136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
    Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
    J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.